undamentalytics Newsletter
Sign in

United Therapeutics Corp balance sheet

At the end of fiscal 2025, United Therapeutics Corp had total assets of $7.88bn, total liabilities of $784m and shareholders' equity of $7.10bn.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1002521681592843988321,0237056697387398959611,2081,6971,5571,803
Receivables517489117126162193215297176151157199220279279350310
Inventory26364637486781100108101938794102112158183194
Total current assets3257645626689149581,2751,4251,4481,7681,8652,1672,3243,3803,5513,8743,7033,484
Goodwill—281111101010143228282828343232—
Total assets1,0521,4321,5181,6272,0881,8842,1842,3262,8793,4013,9134,6155,1696,0457,1677,3647,8807,220
Accounts payable19164710778882310444667—
Total current liabilities330429213177688504441333445277463323305343804738561608
Long-term debt—6971704—————————————
Total debt220305194206286—50500500850800800800700300—0
Total liabilities3885375595327836195854637585931,1331,2201,2101,2481,182920784820
Shareholders' equity6538849481,0841,2591,2431,5891,8512,1022,7892,7803,3953,9594,7975,9856,4447,0966,400
Non-controlling interests and other (assets − liabilities − equity)————45—————————————
Net debt (negative = net cash)1205326472−398−826−1,023−205−16911261−95−161−508−1,397−1,557−1,803
Shares outstanding54m58m54m50m50m47m46m43m43m44m44m45m45m46m47m45m44m43m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BNTX vs UTHRBMRN vs UTHRNTRA vs UTHREXEL vs UTHR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from United Therapeutics Corp's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to United Therapeutics Corp.